Early Access — free while we kick the tires
EdgarHawk

Shelagh Glaser

CFO

Officer

Latest: CFO selling · June 2026

4 filings analyzed · 1 company · Latest 2026-06-15

Companies

Company Buys Sells Direction
SYNOPSYS INC SNPS 0 13 Net selling

Activity

June 2026
2026-06-15 SYNOPSYS INC SNPS
medium
Sell
3,394 shares
$1,527,372
Significance 4/10

SNPS CFO Shelagh Glaser sold 3,394 shares at $450.02 under scheduled 10b5-1 plan

Shelagh Glaser, CFO of Synopsys, sold 3,394 shares (3.4K shares) on 2026-06-12 at $450.02 per share for a total value of $1,527,371.61 ($1.5M), reducing her holdings from 17,752 shares to 14,358 shares (a -19.1% reduction). This transaction was executed under a pre-arranged 10b5-1 trading plan adopted on 2026-01-13, indicating scheduled and non-discretionary activity. At the current price of $457.01, the stock stands -29.9% from its 52-week high of $651.73, and has declined -9.0% over the past 30 days. Across Glaser's five prior SNPS trades, outcomes were mixed: two December 2025 sales showed 30d +12.0% returns followed by 90d -7.1% returns, while a September 2025 pair showed -23.1% at 30 days and -24.0% at 90 days, and a June 2025 sale showed +13.0% at 30 days and +23.9% at 90 days. The scheduled nature of this transaction precludes any characterization based on timing.

December 2025
2025-12-22 SYNOPSYS INC SNPS
low
Sell
3,657 shares
$1,685,036
Significance 4/10

SNPS CFO Shelagh Glaser sells 3,657 shares for $1,685,035.89 on 2025-12-19

Glaser executed 2 separate sales totaling 3,657 shares for $1,685,035.89 on 2025-12-19 at a blended average price of $460.77, reducing her holdings by 17.0% to 17,842 shares. The current price of $481.24 sits 25.4% below the 52-week high of $645.35, despite a strong 23.9% gain over the past 30 days. Reviewing Glaser's cross-ticker track record, her 4 prior sells averaged -0.0% return over 90 days with a 50.00% well-timed rate; at SYNPS specifically, 2 of her 4 prior sales corresponded with subsequent declines (well-timed 90-day mark). The current sale occurs in a context where the stock has recovered recently but remains significantly below its peak, and Glaser's historical pattern shows mixed timing outcomes across both tactics and the specific ticker.

September 2025
2025-09-09 SYNOPSYS INC SNPS
medium
Sell
3,655 shares
$2,228,709
Significance 4/10

SNPS CFO Glaser Shelagh sold 3,655 shares at $609.77 for $2.2M on 2025-09-05, reducing holdings 19.3%

CFO Shelagh Glaser executed 2 separate sales totaling 3,655 shares for $2,228,709.35 at $609.77, reducing her holdings by 19.3% from 18,972 to 15,317 shares. The transaction occurred near the stock's 52-week high ($645.35), though at a -6.4% discount to that peak, and at a price $5.40 above the current market level of $604.37. Glaser's cross-ticker track record shows 2 prior open-market sales with an average 90-day return of +23.9% — indicating that her previous sales missed subsequent gains. Her prior 2 trades at SNPS specifically (both on 2025-06-06) posted identical +23.9% 90-day returns, establishing a pattern of sells that did not precede declines. The filing reflects a material reduction in her stake at elevated valuations, executed while the stock remains up +20.7% over 90 days.

June 2025
2025-06-09 SYNOPSYS INC SNPS
medium
Sell
7,310 shares
$3,550,609
Significance 5/10

CFO Shelagh Glaser sells 7,310 shares at $485.72 for $3.6M; holds 15,291 shares post-sale

Shelagh Glaser, CFO of Synopsys, executed 2 separate sales totaling 7,310 shares for $3,550,608.82 at $485.72 per share on 2025-06-06. The sale reduced her holdings by 32.3% from 22,601 to 15,291 shares. The current stock price of $495.77 is 20.2% below the 52-week high of $621.30, though the stock has risen 2.7% over the prior 30 days and 15.1% over 90 days. Without information on whether this sale was part of a pre-established trading plan, the multiple-transaction structure and the magnitude of the reduction warrant observation of any broader insider activity patterns and company performance in the coming periods.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access